🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 109 of 114

  1. lixisenatide AVE0010

    Sanofi Pasteur

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  2. lomustine

    United Therapeutics Europe Ltd

    Brain and Central Nervous System Tumors

    phase 3 small molecule completed

    1 trial

  3. lorcaserin

    BRIGHT MINDS BIOSCIENCES INC.

    Obesity

    phase 3 small molecule terminated

    1 trial

  4. lorundrostat

    Mineralys Therapeutics

    Hypertension

    phase 3 small molecule active

    1 trial

  5. low titer whole blood

    United Therapeutics Europe Ltd

    Hemorrhagic Shock

    phase 3 mab completed

    1 trial

  6. mCapOX plus Cetuximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  7. mRNA-1010

    Moderna Biotech Spain

    Seasonal Influenza

    phase 3 mab completed

    1 trial

  8. mRNA-1647, Sodium Chloride 0.9%, Solution for Injection

    Moderna Biotech Spain

    Cytomegalovirus Infection (CMV)

    phase 3 small molecule active

    1 trial

  9. mRNA-4157, KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Merck Sharp and Dohme

    The participants must have a histologically confirmed diagnosis of resectable cSCC as the primary site of malignancy (metastatic skin involvement from another primary cancer or from an unknown primary cancer is not permitted).

    phase 3 small molecule active

    1 trial

  10. mRNA-4157, Saline solution for Placebo to v940 (mrna-4157), KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Merck Sharp and Dohme

    Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  11. magnetic stimulation

    Hospital Authority, Hong Kong

    Neuropathic Pain

    phase 3 other completed

    1 trial

  12. mannitol and microcrystalline cellulose, Tolebrutinib

    Genzyme Europe B.V.

    Primary Progressive Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  13. maribavir

    Takeda

    Cytomegalovirus Infections

    phase 3 small molecule completed

    2 trials

  14. maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir

    Takeda

    Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)

    phase 3 small molecule active

    1 trial

  15. masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib

    AB Science

    Amyotrophic Lateral Sclerosis

    phase 3 small molecule active

    1 trial

  16. masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib

    AB Science

    Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  17. matched placebo for test product, Duvakitug

    Sanofi-aventis Healthcare Pty Ltd

    Immune system diseases

    phase 3 small molecule active

    1 trial

  18. mavrilimumab

    Kiniksa Pharmaceuticals International, plc

    COVID

    phase 3 small molecule completed

    1 trial

  19. mesalazine (Asacol®)

    Cardiff Oncology

    Ulcerative Colitis

    phase 3 small molecule completed

    1 trial

  20. metformin

    The First People's Hospital of Lianyungang

    Polycystic Ovary Syndrome

    phase 3 small molecule completed

    1 trial

  21. metformin hydrochloride

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  22. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 3 small molecule completed

    1 trial

  23. methotrexate

    Ultragenyx UK Limited

    Liver Cirrhosis, Biliary

    phase 3 small molecule completed

    1 trial

  24. methylprednisolone

    Ultragenyx UK Limited

    Spinal Cord Injury

    phase 3 small molecule completed

    1 trial

  25. metronomic adjuvant chemotherapy with capecitabine

    Chongqing Claruvis Pharmaceutical Co.,

    Nasopharyngeal Cancinoma (NPC)

    phase 3 small molecule active

    1 trial

  26. mexiletine

    Ultragenyx UK Limited

    Pain

    phase 3 small molecule completed

    1 trial

  27. mifepristone

    CORCEPT THERAPEUTICS INC

    Major Depressive Disorder

    phase 3 small molecule completed

    5 trials

  28. mifepristone

    CORCEPT THERAPEUTICS INC

    Psychotic Depression

    phase 3 small molecule terminated

    1 trial

  29. mifepristone

    CORCEPT THERAPEUTICS INC

    Cushing's Disease

    phase 3 small molecule terminated

    2 trials

  30. mifepristone

    CORCEPT THERAPEUTICS INC

    Cushing's Syndrome

    phase 3 small molecule completed

    2 trials

  31. migalastat HCl 150 mg

    AMICUS THERAPEUTICS PTY LTD

    Fabry Disease

    phase 3 small molecule completed

    1 trial

  32. mipomersen

    IONIS PHARMACEUTICALS INC

    Lipid Metabolism, Inborn Errors

    phase 3 small molecule completed

    2 trials

  33. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Lipid Metabolism, Inborn Errors

    phase 3 small molecule completed

    2 trials

  34. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Heterozygous Familial Hypercholesterolemia

    phase 3 small molecule completed

    1 trial

  35. misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Labor Induction

    phase 3 small molecule completed

    1 trial

  36. mitomycin C-based hyperthermic intraperitoneal chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 other active

    1 trial

  37. mitoxantrone liposome, Ara-Cytarabine and azacitidine

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukaemia

    phase 3 small molecule active

    1 trial

  38. mosapride citrate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Constipation

    phase 3 small molecule completed

    1 trial

  39. muraglitazar

    Bristol-Myers Squibb

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  40. mycophenolate mofetil (CellCept)

    Hoffmann-La Roche

    Myasthenia Gravis, Generalized

    phase 3 small molecule completed

    1 trial

  41. mycophenolate mofetil 2 g per day

    The First People's Hospital of Lianyungang

    Lymphocytic Myocarditis (Disorder)

    phase 3 small molecule completed

    1 trial

  42. nab-paclitaxel combined with carboplatin

    The First People's Hospital of Lianyungang

    Epithelial Ovarian Carcinoma Stage III

    phase 3 small molecule active

    1 trial

  43. nalbuphine HCl ER

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  44. nalbuphine HCl ER

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    2 trials

  45. nalbuphine HCl ER tablets 60 mg BID

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    1 trial

  46. nalbuphine HCl ER tablets 90 mg BID

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  47. naltrexone implant

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    1 trial

  48. neoadjuvant chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Ovarian Cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.